Pliant Therapeutics, Inc.
PLRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001746473
No open-market purchases or sales by Pliant Therapeutics, Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $54.8M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Pliant Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 151
- +8 vs. Q2 2024
- Shares held
- 63.5M
- +4.54M (+7.7%) vs. Q2 2024
- Total value
- $710.6M
- +$76.9M (+12.1%) vs. Q2 2024
- New holders
- 24
- 59 more added
- Sold out
- 16
- 32 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PLRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $54.8M |
| Q1 2026 | 91 | $62.5M |
| Q4 2025 | 98 | $57.0M |
| Q3 2025 | 100 | $74.7M |
| Q2 2025 | 114 | $59.7M |
| Q1 2025 | 141 | $78.5M |
| Q4 2024 | 161 | $852.6M |
| Q3 2024 | 151 | $710.6M |
| Q2 2024 | 144 | $687.2M |
| Q1 2024 | 135 | $971.3M |
| Q4 2023 | 134 | $1.14B |
| Q3 2023 | 136 | $1.04B |
| Q2 2023 | 144 | $1.05B |
| Q1 2023 | 143 | $1.50B |
| Q4 2022 | 125 | $864.1M |
| Q3 2022 | 110 | $948.1M |
| Q2 2022 | 88 | $241.5M |
| Q1 2022 | 92 | $222.1M |
| Q4 2021 | 88 | $416.5M |
| Q3 2021 | 77 | $512.8M |
| Q2 2021 | 81 | $893.6M |
| Q1 2021 | 76 | $1.21B |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Pliant Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 111,660 | $1.25M | 0.01% | +8,037+7.8% | Added |
| UBS Asset Management Americas Inc | 117,937 | $1.32M | 0.00% | +455+0.4% | Added |
| Rhenman & Partners Asset Management AB | 120,250 | $1.35M | 0.11% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 135,122 | $1.51M | 0.00% | −110,450−45.0% | Reduced |
| Exome Asset Management LLC | 149,600 | $1.68M | 1.13% | +25,600+20.6% | Added |
| Rice Hall James & Associates, LLC | 157,217 | $1.76M | 0.10% | +29,583+23.2% | Added |
| Two Sigma Advisers, LP | 157,800 | $1.77M | 0.00% | −31,900−16.8% | Reduced |
| Polar Asset Management Partners Inc. | 170,200 | $1.91M | 0.05% | +123,600+265.2% | Added |
| Bank of New York Mellon Corp | 184,554 | $2.07M | 0.00% | −44,139−19.3% | Reduced |
| Jane Street Group, LLC | 186,726 | $2.09M | 0.00% | −50,772−21.4% | Reduced |
| Capital International Investors | 224,997 | $2.52M | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 230,308 | $2.58M | 0.00% | +78,106+51.3% | Added |
| Millennium Management LLC | 244,640 | $2.74M | 0.00% | +171,350+233.8% | Added |
| ADAR1 Capital Management, LLC | 246,128 | $2.76M | 0.46% | +236,128+2,361.3% | Added |
| ArrowMark Colorado Holdings LLC | 281,189 | $3.15M | 0.04% | 00.0% | Unchanged |
| Mass General Brigham, Inc | 288,690 | $3.24M | 7.42% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 297,362 | $3.33M | 0.55% | +38,808+15.0% | Added |
| Integral Health Asset Management, LLC | 300,000 | $3.36M | 0.40% | +300,000 | New |
| Goldman Sachs Group Inc | 347,397 | $3.89M | 0.00% | +134,159+62.9% | Added |
| AXA S.A. | 347,487 | $3.90M | 0.01% | +980.0% | Added |
| Checkpoint Capital L.P. | 380,000 | $4.26M | 2.11% | +147,800+63.7% | Added |
| Rock Springs Capital Management LP | 384,996 | $4.32M | 0.14% | 00.0% | Unchanged |
| Barclays PLC | 421,499 | $4.73M | 0.00% | +78,575+22.9% | Added |
| Dimensional Fund Advisors LP | 456,166 | $5.11M | 0.00% | +150,844+49.4% | Added |
| Charles Schwab Investment Management Inc | 456,663 | $5.12M | 0.00% | +19,281+4.4% | Added |
| Northern Trust Corp | 502,016 | $5.63M | 0.00% | +24,851+5.2% | Added |
| Fernwood Investment Management, LLC | 513,136 | $5.75M | 1.87% | +16,850+3.4% | Added |
| Bessemer Group Inc | 532,174 | $5.96M | 0.01% | +950.0% | Added |
| Bank of America Corp | 627,696 | $7.04M | 0.00% | +23,451+3.9% | Added |
| Granahan Investment Management Inc | 738,252 | $8.28M | 0.33% | −243,797−24.8% | Reduced |
| Morgan Stanley | 817,123 | $9.16M | 0.00% | +143,276+21.3% | Added |
| Candriam Luxembourg S.C.A. | 833,216 | $9.34M | 0.05% | 00.0% | Unchanged |
| Franklin Resources Inc | 1,039,904 | $14.3M | 0.00% | +14,913+1.5% | Added |
| Pictet Asset Management Holding SA | 1,279,717 | $14.3M | 0.02% | +83,938+7.0% | Added |
| Ra Capital Management, L.P. | 1,281,000 | $14.4M | 0.17% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,318,308 | $14.8M | 0.00% | +31,221+2.4% | Added |
| State Street Corp | 1,402,730 | $15.7M | 0.00% | +26,610+1.9% | Added |
| Deutsche Bank AG | 1,534,365 | $17.2M | 0.01% | +8,201+0.5% | Added |
| Great Point Partners LLC | 1,910,121 | $21.4M | 6.46% | −726,743−27.6% | Reduced |
| Polar Capital Holdings Plc | 2,015,000 | $22.6M | 0.13% | 00.0% | Unchanged |
| TRV GP IV, LLC | 2,132,867 | $23.9M | 14.75% | 00.0% | Unchanged |
| First Light Asset Management, LLC | 2,575,546 | $28.9M | 2.40% | −825,667−24.3% | Reduced |
| Blue Owl Capital Holdings LP | 3,004,199 | $33.7M | 6.53% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 3,104,486 | $34.8M | 1.22% | +3,104,486 | New |
| Redmile Group, LLC | 3,197,491 | $35.8M | 2.11% | −12,100−0.4% | Reduced |
| Vanguard Group Inc | 3,526,514 | $39.5M | 0.00% | +89,354+2.6% | Added |
| FMR LLC | 3,899,481 | $43.7M | 0.00% | −12,278−0.3% | Reduced |
| Price T Rowe Associates Inc | 4,834,813 | $54.2M | 0.01% | +232,490+5.1% | Added |
| BlackRock, Inc. | 5,218,965 | $58.5M | 0.00% | +5,218,965 | New |
| Deep Track Capital, LP | 5,972,257 | $66.9M | 2.14% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 335,480 | – | – | +142,351+73.7% | Added |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −2,498,920−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| PDT Partners, LLC | 0 | $0 | 0.00% | −63,352−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −56,501−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −46,200−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −31,910−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −24,904−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −17,487−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −15,996−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −15,261−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −11,678−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −10,679−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −5,532−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −360−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −104−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |